TNFRSF4 and lupus nephritis: Similarly, although a high percentage of IL-10 secreting cells has been noted in patients with lupus nephritis, in vitro treatment of their peripheral blood mononuclear cells with anti-OX40 therapy reduces IL-10 expression [53].